B
ecause of improvements in cranial base surgery, cavernous sinus meningiomas can now be removed with acceptable rates of morbidity (3, 10, 23) . However, there is still mortality and high morbidity relating to cranial nerve injuries. The usefulness of radiosurgery for cavernous sinus meningiomas was recently reported (5, 9, 12, 14) . It is possible to achieve a significant tumor growth control rate with low morbidity. Nevertheless, cavernous sinus meningiomas often compress the optic apparatus, and surgical resection is recommended in these cases. Radiation doses to the optic apparatus are limited and result in a reduced dose for tumors, which has been reported to correlate with lower tumor growth control rates (1, 12, 24) . But surgical resection is sometimes difficult, even in cases of partial or subtotal removal of tumors that are situated entirely in the cavernous sinus (14) . We planned to treat these lesions primarily by using low-dose radiosurgery (8, 17) , even for tumors that compressed the optic apparatus. We report the usefulness of this strategy for cavernous sinus meningiomas.
PATIENTS AND METHODS
We treated 43 consecutive patients with cavernous sinus meningiomas between January 1994 and December 1999. Patients underwent gamma knife radiosurgery (GKS) with a 201-source cobalt-60 gamma knife (Elekta Instruments, Norcross, GA). Forty-two patients, 36 women and 6 men, were amenable to follow-up, and we evaluated these patients. The age range was 18 to 81 years (mean, 55 yr). Twenty-two patients (52%) underwent surgery before GKS, including 9 patients who were subjected to surgery more than twice because of tumor regrowth. The other 20 patients (48%) were diagnosed only by magnetic resonance imaging (MRI) before radiosurgery. None of the patients had previously received external-beam radiotherapy. Preradiosurgical neurological deficits are shown in Table 1 . Neurological deficits occurred in 21% of patients who underwent surgical resections. Four patients were diagnosed asymptomatically before radiosurgery; their cavernous sinus meningiomas were diagnosed incidentally at screening for other intracranial lesions. Among them, one patient experienced diplopia and facial numbness secondary to left trigeminal and abducens nerve palsy 2 years later, during the period before radiosurgery. Tumor extension was classified according to Sekhar's classification ( Table 2 ) (23) .
The relationship between the optic apparatus and the tumor was examined on magnetic resonance images obtained at radiosurgery. The findings were as follows: tumors compressing the optic apparatus were found in 10 patients (24%), and tumors attached to the optic apparatus occurred in 7 patients (17%); there was some distance (mean, 3.4 mm; range, 1-16 mm) between the optic apparatus and the tumor in 25 patients (59%).
The mean tumor diameters ranged from 13.4 to 58.0 mm (mean, 27.9 mm). The tumor volumes ranged from 1.2 to 101.5 cm 3 (mean, 14.7 cm 3 ). Three patients with a mean tumor diameter greater than 4 cm were treated by two-stage radiosurgery (7, 20) ; their treatment volumes were 1.2 to 30.9 cm 3 (mean, 12.4 cm 3 ). We determined and selected the radiation dose by calculating the volume and its relationship to the integrated logistic equation for 3% risk of permanent brain injury (6) . We also used our previous experience to determine the radiation dose to the optic apparatus (8) . The minimum tumor radiation dose ranged from 8 to 15 Gy (mean, 11 Gy). In the patients with tumors compressing or adhering to the optic apparatus, the tumor marginal dose was reduced to 8 to 10 Gy. Six patients were treated with more than 13 Gy (range, 13-15 Gy; mean, 14 Gy). The 30 to 60% (mean, 49.1%) isodose was used to cover tumors in all treatment procedures. The 30% isodose was used in only one patient, the 40% isodose in three patients, and the 60% isodose in one patient; the other 38 patients (90.5%) were treated with a 50% isodose.
The radiation dose to the optic apparatus was measured by the highest dose to the optic apparatus on the computer dose plan (Kula system or Gamma-Plan, Elekta Instruments). The optic apparatus was irradiated with a maximum of 2 to 12 Gy (mean, 6.2 Gy). Two patients were irradiated at the optic apparatus with more than 12 Gy because the tumor encased the optic nerve and blindness had already occurred in the affected eye before radiosurgery. One patient had the optic apparatus irradiated twice by GKS. The optic nerve was irradiated with a maximum of 8 and 10 Gy at the first and second treatments, respectively.
All patients were discharged the day after GKS without acute radiation injury, such as nausea and vomiting. Follow-up imaging was requested at 6-month intervals for the first 3 years and at 1-year intervals after 3 years. Tumor reduction was calculated as any measurable reduction in either the anteroposterior or mediolateral dimensions of the tumor.
RESULTS
The median follow-up period was 49.4 months (range, 18-84 mo). At the final observation, tumor regression was observed in 25 patients (59.5%), and the tumor was unchanged in 13 patients (31%). Regrowth or recurrence was observed in four patients (9.5%). The tumor growth control rate was 95.2% in patients who had not undergone operations before radiosurgery and 86.3% in patients who had undergone preradiosurgical operations. There was no statistical difference between these groups (P ϭ 0.73).
The actual tumor growth control rate at 5 years was 92% (Fig. 1) . However, only one patient (2.4%) experienced regrowth within the treatment field; regrowth was noted 5.6 years after GKS. Other tumor regrowth or recurrence was peripheral to or outside the treatment field. Of the four patients with tumor regrowth, three were retreated by radiosurgery. One patient with tumor growth at the cerebellopontine angle outside the GKS treatment region 3 years after GKS had rapid tumor progression and subsequently underwent surgery; histological examination revealed an anaplastic meningioma (MIB-1 index, 20.5%). The carotid narrowing observed at GKS did not change, instead of changing the tumor size. We did not find carotid stenosis or occlusion resulting from radiation injury.
The details of retreatment with GKS for tumor growth are as follows. One patient, who had undergone two previous operations for a sphenoid ridge meningioma, underwent the first GKS for a recurrent tumor in the cavernous sinus. The patient was retreated with GKS 2.8 years after the first GKS because the tumor had recurred in the middle fossa and outside the site of the previous GKS. Eight months after the second GKS, the tumor recurred and extended into the optic canal and orbital apex. At that time, the patient did not desire another surgical operation and was retreated with a third GKS. This time, the left optic nerve was irradiated with more than 12 Gy, because the affected eye was blind as a result of tumor extension.
In another patient, GKS had first been performed for a left cavernous sinus meningioma after partial removal during a previous operation. Regrowth to the cerebellopontine angle region was retreated by a second GKS 2.8 years after the first one. The tumor then extended to the pituitary fossa and clivus and was retreated with a third GKS 4.1 years after the first GKS. Subsequently, the tumor recurred as a petrocavernous lesion (within the treatment field) and in the middle fossa 5.6 years after the first GKS, and the patient underwent a fourth GKS. This patient's condition is stable, with only a mild left abducens nerve palsy and facial numbness.
A third patient was treated by GKS for a residual tumor after a previous operation for a cavernous sinus meningioma. The tumor recurred at the pituitary fossa, and the patient was retreated 3 years after the first GKS.
Twelve patients (29%) improved clinically, and 27 (64%) were unchanged. Only three patients (7%) experienced deterioration of their clinical status. Of these three patients, two developed tumor growth outside the treatment field, and one patient deteriorated with preexisting ptosis. The details of cranial nerve function after radiosurgery are listed in Table 3 . Of the nine patients with visual disturbances, one (11%) improved and one (11%) was relieved of pretreatment homonymous hemianopia (Fig. 2) . The visual disturbance in another patient deteriorated because of tumor extension into the optic canal outside the treatment field. Of the nine patients with an oculomotor palsy, symptoms disappeared in one (11%) and improved in another (11%). One patient had slight deterioration of preexisting ptosis 48 months after radiosurgery, but without tumor growth. Of the 18 patients with trigeminal neuropathy, improvement occurred in two (11%) and symptoms disappeared in one (5.5%). Of the 11 patients with abducens nerve palsy, improvement occurred in one (9%) and symptoms disappeared in one (9%). The one patient with tumor regrowth at the cerebellopontine angle experienced cerebellar ataxia.
We treated three patients without symptoms. None of these patients experienced neurological deficits after GKS (Fig. 3) . In one patient who had been diagnosed incidentally with tumor growth during the preradiosurgical follow-up period, the tumor size was markedly decreased and the preexisting trigeminal neuropathy was improved after GKS.
Two patients (4.7%) sustained radiation injuries. In one patient, an asymptomatic radiation injury at the temporal lobe was observed on T2-weighted magnetic resonance images 24 months after GKS and disappeared 36 months after GKS. One patient experienced a generalized convulsion 1 month after radiosurgery. This was probably secondary to a radiation injury at the temporal lobe that was without changes on imaging.
DISCUSSION
The results of surgery as a treatment for cavernous sinus meningiomas have improved with the use of modern microsurgical techniques, but surgery is still accompanied by some morbidity (3, 23). Sekhar et al. (23) operated on 114 patients and achieved a 78% rate of total removal and a 43% rate of preserving the same or better postoperative extraocular muscle functions. One hundred eight patients (95%) could return to their previous occupations but still had high rates of postoperative ocular dysfunction. They also experienced 20% regrowth after incomplete resection at 3.9 years of follow-up. Knosp et al. (10) reported operative results for 29 patients with cavernous sinus meningiomas. Cranial nerve function improved in 7 to 50% of patients and deteriorated in 14 to 58%, depending on the cranial nerve involved. DeMonte et al. (3) also operated on 41 patients with cavernous sinus meningiomas and reported that total removal could be achieved in 76% of patients. Cranial nerve function improved in 14%, remained unchanged in 80%, and worsened in 6%. The patients experienced major operative complications such as vasospasm or 
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NEUROSURGERY VOLUME 52 | NUMBER 3 | MARCH 2003 | 519 hypothalamic dysfunction. Nonetheless, these surgical results were probably among the best results of experienced neurosurgeons in this field. The usefulness of fractionated radiotherapy for cranial base meningiomas has been reported. Nutting et al. (18) reported that conventional fractionated external-beam radiation could achieve an 83% rate of 10-year progression-free survival for cranial base meningioma patients without new cranial neuropathy. Dufour et al. (4) treated 31 patients with cavernous sinus meningiomas by external-beam radiotherapy and achieved a 92.8% rate of 10-year tumor growth control; none of their patients developed late radiation toxicity. These results suggest that radiation therapy is useful for these lesions from the standpoint of long-term tumor growth control and preservation of cranial nerve function.
Radiosurgery may be considered less invasive than conventional radiation therapy from the standpoint of radiation effects on surrounding structures. Also, long-term malignant transformation is likely to occur much less frequently with radiosurgery than with radiotherapy because of the smaller volume of normal tissue irradiated. If radiosurgery has the same results as conventional radiation therapy for tumor growth control and preservation of cranial nerve function, radiosurgery is indicated instead of conventional radiation therapy.
The usefulness of radiosurgery for meningiomas has been reported (11, 16) . There have been several reports of cavernous sinus meningiomas treated by GKS ( Table 4) Chang et al. (1) reported the results of using linear accelerator radiosurgery for the treatment of cavernous sinus meningiomas. They treated 24 patients, with a mean follow-up period of 45.6 months. They used an average radiation dose of 17.7 Gy. Tumor growth control was achieved in 100% of the patients. Four of the patients (17%) experienced facial hypesthesias, and one patient (4%) had worsening of diplopia. They also treated one patient (4%) with symptomatic radiation necrosis and one patient (4%) with asymptomatic radiation injury.
The radiation dose for the optic apparatus is very important for the radiosurgical treatment of cavernous sinus meningio- a GKS, gamma knife radiosurgery. b In this patient, the deterioration is a result of tumor extension to the optic canal.
mas because these tumors often are adjacent to or compressing the optic apparatus. Tishler et al. (25) reported that the cranial nerves in the cavernous sinus could tolerate approximately 40 Gy, but there was a 24% incidence of visual disturbances when the optic apparatus received radiation of more than 8 Gy during radiosurgery. Leber et al. (13) reported that the optic nerve could be irradiated with less than 10 Gy with no complications. However, a radiation dose of 10 to 15 Gy had a 26.5% risk of optic neuropathy, and doses greater than 15 Gy had a 77.8% risk of optic neuropathy. Also, cranial nerves in the cavernous sinus could be irradiated with a mean of 14.1 Gy and the trigeminal nerve with a mean of 12.9 Gy without any new deficits. In our study, 41% of the patients had tumors that compressed or were attached to the optic apparatus. In previous reports of radiosurgery for cavernous sinus meningiomas, the radiation doses for these tumor margins ranged from means of 11 to 17.7 Gy. Depending on an optimal dose for the tumor margin, the tumors close to or adhering to the optic nerve would have to be resected before radiosurgery to prevent optic neuropathy. In these situations, the most suitable approach may include decompression of the tumor mass to increase the distance between the optic apparatus and the tumor. However, surgical resection carries the possibility of some morbidity. We reduced the tumor marginal dose to 8 to 10 Gy in tumors adhering to or compressing the optic apparatus. We also planned radiation doses to the optic apparatus that would not exceed 10 Gy. If the tumor compressed the optic apparatus, we did not use a beam-blocking pattern, and the marginal dose was kept a small distance away from the optic apparatus. In these cases, the tumor close to the optic apparatus could be irradiated with less than 6 Gy without permitting regrowth of the tumor. Perhaps if most of the tumor receives a sufficient dose, the entire tumor does not require the same dose. We still consider the optimal dose for the meningioma to be 12 Gy to the tumor margin, but from our experience, a reduced radiation dose of 8 to 10 Gy may be acceptable for cavernous sinus meningiomas close to the optic apparatus. Our actual tumor growth control at 5 years was 92%. However, among our patients with tumor recurrence or regrowth, only one patient (2.4%) experienced regrowth within the radiosurgical treatment field. Other recurrences or cases of regrowth occurred outside or peripheral to the treatment site. One patient experienced a recurrence, and, at that time, the tumor showed malignant changes (MIB-1 index, 20.5%). Randle et al. (21) reported that recurring meningiomas had a tendency to become malignant. We did not note a relationship between malignant change of the tumor and radiosurgery because the tumor recurred outside the treatment field. This means that tumor growth control by radiosurgery could be achieved in 97.6% of the patients in our series with more than 4 years of follow-up. Long (15) commented that symptoms of patients with cavernous sinus meningiomas were very mild and that radical resection had a high morbidity. Also, radiosurgery was much less invasive and had lower morbidity than surgical resection. But he noted that long-term follow-up would still need to be evaluated to assess the usefulness of radiosurgery for these lesions. Our study will also require further long-term follow-up.
We think that a patient with an asymptomatic cavernous sinus meningioma may also be a candidate for radiosurgery if the tumor is growing, because patients who develop neurological deficits during the observation period experience a decrease in quality of life with the deterioration of the cranial neuropathy. We studied one patient who developed diplopia before radiosurgery during the follow-up period. We believe that cavernous sinus meningiomas must be treated by radio- surgery before patients sustain neurological symptoms. This is evidenced by our treatment data after radiosurgery showing very low rates of radiation injury, high rates of tumor growth control, and preservation of cranial nerve function.
CONCLUSION
Cavernous sinus meningiomas, even those compressing or close to the optic apparatus, can be treated by radiosurgery without surgical resection with low morbidity and long-term tumor growth control. 
W
ith the publication of this clinical series, Iwai et al. have added more fuel to the fire in the debate over the treatment of cavernous sinus meningiomas. The treatment group is similar to those in other series of gamma knife radiosurgery for cavernous sinus meningiomas. About half of the patients had undergone prior surgical resections, and half were treated on the basis of the magnetic resonance imaging diagnosis. The contribution of this article is the mean 4-year follow-up after the use of relatively low doses to spare the optic apparatus. The mean dose to the tumor periphery in this series was only 11 Gy. Low doses were mandated in patients whose tumors abutted the optic nerves and chiasm. The optic structures received a mean dose of 6.2 Gy, which is well within the generally accepted single-fraction doses. In selected cases, however, doses were as high as 12 Gy to the optic apparatus. The 5-year control rate was 86%. On the basis of these results, the authors propose gamma knife radiosurgery as both safe and effective for cavernous sinus meningiomas.
Conventional external beam radiotherapy serves as the standard for radiation treatment of cavernous sinus meningiomas in terms of safety and efficacy (1). Equivalent control rates have been reported with external beam radiotherapy over similar and longer periods of follow-up (1). Similarly, low complication rates have been demonstrated. The series of Iwai et al. had a nearly 5% incidence of temporal lobe radiation injury. This is bound to happen with single-fraction radiosurgery when larger tumors and volumes are treated. More importantly, Iwai et al. themselves point out that most of their treatment failures occurred outside the treated volumes or at the periphery. These could be alternatively interpreted as "marginal recurrences." This is perhaps the strongest argument to avoid single-fraction radiosurgery in larger meningiomas. With radiosurgery, the temptation is always to limit the treated volume so that the risk of complications is reduced. External beam radiotherapy classically includes a margin
